Pharmasova SA
Pharmasova reported total assets of €38.9m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jan 2026).
The score of Pharmasova shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1 % Total assets -4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmasova's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 30 Jan 2026
- Year ended 30 Jun 2024filed on 10 Feb 2025
- Year ended 30 Jun 2023filed on 06 Feb 2024
- Year ended 30 Jun 2022filed on 01 Mar 2023
- Year ended 30 Jun 2021filed on 09 Feb 2022
Pharmasova's financial analysis
- Solvency71.8%sector median: 60.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmasova
Pharmasova's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0864.058.578
- VAT number
- BE0864058578
- Peppol
- Registered · 0208:0864058578 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Jun 2003
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2025 · filed on 30 Jan 2026
- Activity
- Activities of holding companies (NACE 64210)
Pharmasova (SA) has been based in Anderlecht since 2003, active in: activities of holding companies. For 2025, it reports a net profit of €1.85m and equity of €27.9m; its revenue is not published. Its solvency stands at 71.8%, above the median of its sector (60.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmasova
Companies in the same business, of comparable size and area, outside its group.
- Hospidex Group Activities of holding companies Tienen · balance sheet €45.0m
- Medenvision International Activities of holding companies Westerlo · balance sheet €55.3m
- Telemis Holding Activities of holding companies Ottignies-Louvain-la-Neuve · balance sheet €14.2m
- Medical Holding Activities of holding companies Halen · balance sheet €44.8m
- Wim de Marez Activities of holding companies Schaerbeek · balance sheet €8.97m
- Palex Healthcare Group Belgium Activities of holding companies Mechelen · balance sheet €26.8m
- JM Capital Activities of holding companies Ranst · balance sheet €23.2m
- Bobbie Pharmaceutical Services Activities of holding companies Wingene · balance sheet €47.0m
Frequently asked questions about Pharmasova
What is the revenue of Pharmasova?
Pharmasova files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmasova?
In Belgium, the VAT number is the company number prefixed with BE: BE0864058578 for Pharmasova, if the company is VAT-registered. Its company number (CBE) is 0864.058.578.
Where is the registered office of Pharmasova?
According to the CBE register, the registered office of Pharmasova is in 1070 Anderlecht.
What is the equity of Pharmasova?
At the close of the 2025 financial year, the equity of Pharmasova amounts to 27,928,969 €, a solvency of 71.8% of total assets.
Who manages Pharmasova?
The register lists 5 active mandates at Pharmasova. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmasova
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →